Back to Search
Start Over
Response to 'Comment on ‘Optimal Exposure Biomarkers for Nonpersistent Chemicals in Environmental Epidemiology’'
- Source :
- Environmental Health Perspectives. 124
- Publication Year :
- 2016
- Publisher :
- Environmental Health Perspectives, 2016.
-
Abstract
- We appreciate the opportunity to respond to the letter from Stahlhut et al. regarding our Brief Communication. We stressed the importance of biospecimen integrity and the potential danger of unrecognized contamination of convenience samples, particularly with ubiquitous environmental chemicals such as bisphenol A (BPA) and phthalates. We did not discuss the important area of experimental research and specifically pharmacokinetic studies, although we based our argument partly on knowledge of concentration changes in various compartments postexposure. We agree that information from pharmacokinetic models is quite valuable and note that experimental studies that use isotope-labeled materials are not susceptible to extraneous contamination. Such experimental studies do not support using polar metabolites, such as unmetabolized BPA, as biomarkers in epidemiologic studies (Thayer et al. 2015). For example, even in situations that may result in exposures higher than background levels, such as handling cash register receipts, BPA serum concentrations are below or near the detection limit and much lower than urinary concentrations (Thayer et al. 2016). The figure in our Brief Communication revealed the sharp increase in the number of publications using blood-based polar biomarkers over the past 15 years, especially etiologic studies. Our main point was that urine is the most dependable biomonitoring matrix for population research, a position that Stahlhut et al. also support in their letter. Target-organ dose may inform biological models, but measuring this dose is not always possible, although it can be inferred from pharmacokinetic studies. For environmental epidemiology, reliable measurements in urine can be used to quantify exposures. A suitable exposure biomarker involves more than detecting the analyte with precise and accurate methods. For pervasive chemicals and particularly for archived samples, specimen integrity must be confirmed. This is true for any matrix, including urine (Guidry et al. 2015; Koch et al. 2012), to ensure valid results.
- Subjects :
- Specimen integrity
Health, Toxicology and Mutagenesis
Population research
Public Health, Environmental and Occupational Health
Environmental exposure
010501 environmental sciences
030501 epidemiology
Serum concentration
Biology
01 natural sciences
Experimental research
03 medical and health sciences
Environmental health
Environmental chemistry
Biomonitoring
Biomarker (medicine)
0305 other medical science
0105 earth and related environmental sciences
Environmental epidemiology
Subjects
Details
- ISSN :
- 15529924 and 00916765
- Volume :
- 124
- Database :
- OpenAIRE
- Journal :
- Environmental Health Perspectives
- Accession number :
- edsair.doi...........a2f57c59dde4f08079ce3ca5e489f03c
- Full Text :
- https://doi.org/10.1289/ehp.1611282